Ftse Mib
39.022,40
0,95%
DAX
23.154,57
0,94%
S&P 500
5.675,12
0,64%
NASDAQ
17.808,66
0,31%
Bitcoin
83.097,79
-1,14%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Ipsen SA (I7G) Ipsen SA (I7G) Notizie

Ipsen SA

I7G
111,60
1,80 (1,64%)
17 Mar 2025 - Chiuso
Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
12/3/202507:28UKREGIpsen nomme Olivia Brown au poste de Vice-Présidente..
12/3/202507:28UKREGIpsen appoints Olivia Brown as Executive Vice-President,..
06/3/202518:00UKREGIpsen - Février 2025 - Information mensuelle relative au..
06/3/202518:00UKREGIpsen - February 2025 - Monthly information relative to the..
21/2/202515:42UKREGIpsen S.A. publie ses comptes consolidés 2024
21/2/202515:42UKREGIpsen S.A. publishes its 2024 consolidated financial..
13/2/202506:57UKREGIpsen réalise de solides résultats en 2024, grâce à la bonne..
13/2/202506:57UKREGIpsen delivers solid results in 2024, driven by strong..
06/2/202518:00UKREGIpsen - January 2025 - Monthly information relative to the..
06/2/202518:00UKREGIpsen - Janvier 2025 - Information mensuelle relative au..
07/1/202518:00UKREGIpsen - Bilan semestriel - 31 12 2024
07/1/202518:00UKREGIpsen - Half year statement - 2024 12 31
07/1/202518:00UKREGIpsen - December 2024 - Monthly information relative to the..
07/1/202518:00UKREGIpsen - Décembre 2024 - Information mensuelle relative au..
09/12/202418:00UKREGIpsen - Novembre 2024 - Information mensuelle relative au..
09/12/202418:00UKREGIpsen - November 2024 - Monthly information relative to the..
03/12/202407:00UKREGIpsen et Biomunex annoncent un accord de licence mondial..
03/12/202407:00UKREGIpsen and Biomunex announce exclusive global licensing..
18/11/202407:00UKREGBylvay® (odévixibat) montre une amélioration soutenue en..
18/11/202407:00UKREGBylvay® (odevixibat) data shows sustained improvement in..
15/11/202417:00UKREGIqirvo® (elafibranor) data shows efficacy and safety for up..
15/11/202417:00UKREGIqirvo® (elafibranor) montre des données d’efficacité et de..
07/11/202418:00UKREGIpsen - October 2024 - Monthly information relative to the..
07/11/202418:00UKREGIpsen - Octobre 2024 - Information mensuelle relative au..
23/10/202407:00UKREGIpsen delivers strong sales momentum in the first nine..
23/10/202407:00UKREGIpsen enregistre une forte dynamique commerciale au cours..
14/10/202418:00UKREGIpsen reçoit un deuxième prix Shingo pour son excellence..
14/10/202418:00UKREGIpsen receives its second Shingo Prize for operational..
09/10/202418:00UKREGIpsen - Septembre 2024 - Information mensuelle relative au..
09/10/202418:00UKREGIpsen - September 2024 - Monthly information relative to the..
23/9/202413:13UKREGLe médicament Kayfanda® (odévixibat) d’Ipsen est approuvé..
23/9/202413:13UKREGIpsen’s Kayfanda® (odevixibat) approved in European Union..
20/9/202414:57UKREGIpsen’s Iqirvo® (elafibranor) approved in the European Union..
20/9/202414:57UKREGLe médicament Iqirvo® (élafibranor) d’Ipsen est approuvé..
16/9/202414:45UKREGFinal results from CABINET Phase III trial reinforce..
16/9/202414:45UKREGLes résultats finaux de l’essai de Phase III CABINET..
15/9/202414:45UKREGIpsen provides update on CONTACT-02 Phase III trial in..
15/9/202414:45UKREGIpsen communique de nouvelles données sur l’essai de Phase..
04/9/202418:00UKREGIpsen - August 2024 - Monthly information relative to the..
04/9/202418:00UKREGIpsen - Août 2024 - Information mensuelle relative au nombre..
13/8/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
13/8/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024
06/8/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2024
06/8/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
05/8/202418:00UKREGIpsen - Juillet 2024 - Information mensuelle relative au..
05/8/202418:00UKREGIpsen - July 2024 - Monthly information relative to the..
30/7/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2024
30/7/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
26/7/202412:46UKREGIpsen receives CHMP positive opinions for Iqirvo®..
26/7/202412:46UKREGIpsen reçoit des avis positifs du CHMP pour Iqirvo®..
Apertura: 110,20 Min: 110,00 Max: 110,80
Chiusura: 109,80

La tua Cronologia

TG
I7G
Ipsen
TG
S8V
Shurgard Self Storage
XE
MBG
MercedesBenz
TG
7RZ
Augusta Gold
TG
36M
Shockwave Medical
TG
RX4
Skycity Entertainment
TG
OWQ
Arbor Realty
TG
COZ
Cognizant Tech Sol A
TG
6HT
Haitong Securities
TG
R2K
Restaurant
TG
T9Z
Zumtobel
TG
MJ8
Mcdonald S Hldg Co J
TG
75H
Country Garden Services
TG
31R
Revive Therapeutics
TG
MEB
Medincell
TG
NNL
Monex
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci